Post -infectious asthenia in the era of new coronavirus infection: approaches to drug correction

Authors:
E.Yu. Ebzeeva, O.D. Ostroumova

Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Health of the Russian Federation

Place of publication:
NEW THERAPEUTIC JOURNAL "NON NOCERE", DECEMBER, 2020

Abstract:
Asthenia (Greek for “impotence”, “lack of strength”) is a protective and compensatory reaction of the body to any condition that threatens the depletion of energy resources, and according to the definition in ICD-10 – “a constant sensation and/or complaints of a feeling of general weakness, increased fatigue (with any type of load), as well as decreased performance in combination with 2 or more of the following complaints: muscle pain; tension headaches; dizziness; sleep disturbances; dyspepsia; inability to relax; irritability”.

Clinical manifestations of asthenic syndrome (AS) can be divided into:

• physical (muscle weakness, fatigue, exhaustion);

• emotional and psychological (emotional lability, irritability, feeling of internal tension, low mood, apathy);

• cognitive (decreased mental performance, memory, concentration);

• sleep disorders (insomnia, drowsiness).